Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2022. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 188351000087114 | SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 188361000087112 | SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 188371000087115 | COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL mRNA Mod | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 188381000087118 | COVID-19 SPIKEVAX vaccin bivalent (Original / Omicron BA.4/BA.5) contre la COVID-19 0.10 mg/mL ARNm Mod | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | Has supplier | Moderna Therapeutics Inc. | true | Inferred relationship | Some | ||
| SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | est un(e) (attribut) | COVID-19 messenger ribonucleic acid unspecified | true | Inferred relationship | Some | ||
| SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | a pour principe actif (attribut) | acide ribonucléique messager du coronavirus du syndrome respiratoire aigu sévère 2 (substance) | true | Inferred relationship | Some | 1 | |
| SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) messenger ribonucleic acid 0.10 milligrams per 1 milliliter dispersion for injection Moderna Therapeutics Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Administered tradename codes for vaccines reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR